Largest Insider Trades of the Week

Insiders invest in WideOpenWest, dump Genomic Health

Author's Avatar
Mar 22, 2019
Article's Main Image

The GuruFocus Insiders page can be used to find insider trades from the past week. Display trades with at least 100,000 shares traded as buys and then sales.

According to these filters, the following are trades from company insiders this week.

Crestview Partners III GP L.P., director and 10% owner of WideOpenWest Inc. (WOW, Financial), bought 226,635 shares for an average price of $9.32 per share on March 19.

68dbdb80-4bca-11e9-a5e6-21c1af3b54fb.png

The company, which supplies cable and broadband services, has a market cap of $762.13 million and an enterprise value of $3.04 billion. It has insider ownership of 3.41% and institutional ownership of 67.01%.

Over the last 12 months, the stock has climbed 26% and is trading 28.58% below its 52-week high and 53.03% above its 52-week low.

Blackstone Infrastructure Asso., Blackstone Holdings III L.P. and Enagas U.S.A. LLC bought a combined 853,500 class A shares of Tallgrass Energy LP (TGE, Financial) for an average price of $24.07 per share on March 18.

24a52990-4bcb-11e9-8b66-9b7e6c81cb02.png

The company, which acquires and develops midstream energy assets in North America, has a market cap of $6.92 billion and an enterprise value of $10.61 billion. It has insider ownership of 72.3% and institutional ownership of 0.71%.

Over the last 12 months, the stock has gained 39% and is trading 6.30% below its 52-week high and 44.05% above its 52-week low.

Rocco A. Ortenzio, vice chairman of Select Medical Holdings Corp. (SEM, Financial), bought 306,189 shares for an average price of $14.18 per share on March 18.

b5a33dd0-4bcb-11e9-a35b-07afd7b27bf4.png

The company, which provides long-term acute care hospital services, has a market cap of $1.95 billion and an enterprise value of $5.21 billion. It has insider ownership of 107.6% and institutional ownership of 13.93%.

Over the last 12 months, the stock has fallen 20% and is trading 33.30% below its 52-week high and 6.65% above its 52-week low.

Armistice Capital Master Fund, 10% owner of Del Frisco's Restaurant Group Inc. (DFRG, Financial), bought 319,000 shares for an average price of $6.52 per share on March 20.

2579b500-4bcc-11e9-a074-4da0704b393b.png

The company, which operates three restaurant chains, has a market cap of $216.6 million and an enterprise value of $545.01 million. It has insider ownership of 143.56% and institutional ownership of 2.87%.

Over the last 12 months, the stock has tumbled 55% and is trading 61.88% below its 52-week high and 10.58% above its 52-week low.

Most important insider sales

Baker Bros. Advisors LP, 10% owners and directors of Genomic Health Inc. (GHDX, Financial), sold 270,006 shares for an average price of $74.45 per share on March 19.

0ab734c0-4bce-11e9-8a84-c3c22cf4fa8b.png

The health care company has a market cap of $2.71 billion and an enterprise value of $2.5 billion. It has insider ownership of 5.89% and institutional ownership of 114.55%.

Over the last three months, the stock has soared 131% and is trading 20.53% below its three-month high and 144.41% above its 3-month low.

VenBio Select Advisor LLC, 10% owner of Mirati Therapeutics Inc. (MRTX, Financial), sold 248,781 shares for an average price of $74.94 per share on March 20.

8b6bb770-4bce-11e9-8332-e9a874d80a5c.png

The biotechnology company has a market cap of $2.57 billion and an enterprise value of $2.34 billion. It has insider ownership of 0.71% and institutional ownership of 145.21%.

Over the last 12 months, the stock has climbed 125% and is trading 9.04% below its 52-week high and 195.21% above its 52-week low.

Kenneth C. Frazier, chairman and president of Merck & Co. Inc. (MRK, Financial), sold 192,736 shares for an average price of $82.05 per share on March 20.

5c7d0990-4bd1-11e9-8ff0-832ffc519544.png

The health care company has a market cap of $211.87 billion and an enterprise value of $228.3 billion. It has insider ownership of 0.11% and institutional ownership of 115.84%.

Over the last 12 months, the stock has risen 52% and is trading 0.77% below its 52-week high and 55.37% above its 52-week low.

CEO Mark V. Hurd and Executive Vice President Jeffrey Henley sold a combined 1,600,000 shares of Oracle Corp. (ORCL, Financial) for an average price of $54 per share on March 19.

033e0030-4bd2-11e9-82d6-873f02b50382.png

The software company has a market cap of $179.91 billion and an enterprise value of $196.56 billion. It has insider ownership of 28.59% and institutional ownership of 84.49%.

Over the last 12 months, the stock has risen 15% and is trading 3.19% below its 52-week high and 24.15% above its 52-week low.

Disclosure: I do not own any stocks mentioned.

Read more here: